Dr Marzena Pedrini has received a MSWA Postdoctoral Fellowship through UWA for 2 years which includes projects; “Exploring the mechanisms of MS pathogenies” and the HSCT (stem cell) register.

MS Research Australia Incubator Grant 2018

Trend S, Jones AP, Cha L, Byrne SN, Geldenhuys S, Fabis-Pedrini MJ, Carrol WM, Cole JM, Booth DR, Lucas RM, Kermode AG, French MA, Hart PH. Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome. Front. Immunol. 9:1590. doi: 10.3389/fimmu.2018.01590

The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis. Fewings NL, Gatt PN, McKay FC, Parnell GP, Schibeci SD, Edwards J, Basuki MA, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Manrique CP, McCauley JL, Nickles D, Baranzini SE, Burke T, Vucic S, Stewart GJ, Booth DR. Journal of Autoimmunity. 2017 Jan 4. pii: S0896-8411(16)30284-0. doi: 10.1016/j.jaut.2016.12.006.

Fabry heterozygote mimicking multiple sclerosis. Marzena Fabis-Pedrini, Allan G Kermode. BMJ Case Reports (2017) DOI: 10.1136/bcr-2017-220274

Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis. Fewings N, Gatt PN, McKay FC, Parnell GP, Schibeci SD, Edwards J, Basuki MA, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Manrique CP, McCauley JL, Nickles D, Baranzini SE, Burke T, Vucic S, Stewart GJ, Booth DR. Data in Brief. (2017) Feb 21;11:364-370. DOI: 10.1016/j.dib.2017.02.040

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. Kalincik T, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Lechner-Scott J, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Solaro C, Grand’Maison F, Hupperts R, Prevost J, Sola P, Ferraro D, Terzi M, Butler E, Slee M, Kermode A, Fabis-Pedrini M, McCombe P, Barnett M, Shaw C, Hodgkinson S, Butzkueven H; MSBase Study Group. Mult Scler. 2017. Aug 1:1352458517728812. doi: 10.1177/1352458517728812

Acute reversible seronegative cerebellar ataxia in a young woman with ovarian teratoma. Yau WY, Fabis-Pedrini MJ, Kermode AG. J Neurol Sci. 2016 Oct 15;369:227-8. doi: 10.1016/j.jns.2016.08.033. Epub 2016 Aug 16

Mahurkar S, Moldovan M, Suppiah V, Sorosina M, Clarelli F, Liberatore G, Malhotra S, Montalban X, Antigüedad A, Krupa M, Jokubaitis VG, McKay FC, Gatt PN, Fabis-Pedrini MJ, Martinelli V, Comi G, Lechner-Scott J, Slee M, Taylor BV, Vandenbroeck K, Comabella M, Martinelli F, Boneschi MD, The Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), King C. Response to Interferon Beta Treatment in Multiple Sclerosis patients – A Genomewide Association Study. Pharmacogenomics J. 2016 Mar 22. doi: 10.1038/tpj.2016.20.

MSWA Post-Doc Fellowship 2016-2018